Partnering Opportunities
Assets available for co-development and licensing
Opportunities for orphan biosimilar candidates
Valerius is developing its orphan drug biosimilar candidates until market approval. We are seeking for biopharmaceutical companies as reliable strategic partners to support marketing and sales activities for our orphan biosimilar assets.
Opportunities for non-orphan biosimilar candidates
Valerius offers the opportunity of licensing non-orphan drug biosimilar candidates after proof-of-biosimilarity, based on comparative quality studies. We also remain open for other collaboration opportunities, e.g. co-developments, to support further non-clinical and clinical development of our non-orphan biosimilar assets.